And these seem like faraway scenarios, but if you consider the  fact that we might not have antibiotics for many  people who have infections, we might consider the fact that we might want to allocate who actually gets to use some of these antibiotics over others, and some of these might have to be on the basis of clinical need, but also on the basis of pricing.
Pode que parezan posibilidades remotas, pero se se tivera en conta o feito de que quizais non hai antibióticos suficientes  para todos os infectados, poderiamos contemplar asignar algúns destes antibióticos a uns pacientes e non a outros, en función das necesidades clínicas, pero tamén do prezo do tratamento.